About Cambridge Healthtech Institute
CHI’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US, including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk, World Pharmaceutical Congress, and the newly acquired Bio-IT World’s Life Sciences Conference & Expo.
The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with a heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 600 conferences, attracting more than 50,000 attendees from around the world.
In addition to CHI’s vast conference portfolio, their media properties include Pharma DD and Bio-IT World.
About Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of Bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government, and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance.
The company’s premier publication, Bio-IT World, and accompanying Web site, www.bio-itworld.com, deliver the latest news, analysis, and information on the tools and equipment, information technology and informatics, and business strategies driving innovation in the Bio-IT community. Bio-IT World has received more than 35 awards for editorial and design excellence. For advertising opportunities visit
About Pharma DD
Pharma DD, published 6x per year, provides senior researchers and scientific management with unique insight into the industry-leading techniques and approaches driving new therapeutic discovery and development. As well as focusing on business issues, regulatory considerations, clinical trials, and post-approval safety issues.
The publication and accompanying website www.pharmadd.com, deliver features, news, commentaries, and case studies to professionals in pharma, biotech, and research laboratories. For advertising opportunities visit www.pharmadd.com/mediakit